業績番号：2019-10
N.Tsuchiya, R.Zhang, T.Iwama, N.Ueda, T.Liu, M.Tatsumi, Y.Sasaki, R.Shimoda, Y.Osako, Y.Sawada, Y.Kudo, A.Miyashita, S.Fukushima, Z.Cheng, R.Nakaki, K.Takubo, S.Okada, S.Kaneko, H.Ihn, T.Kaisho, Y.Nishimura, S.Senju, I.Endo, T.Nakatsura and Y.Uemura.
Type-I interferon delivery by iPSC-derived myeloid cells elicits antitumor immunity via XCR1+ dendritec cells.
Cell Reports 29(1); 162:175.e9.;2019.10.1
31577946
